Showing results (151-160 of 16,628) with videos related to
Sort By:
Pageof 1,663
Cancer Letters|August 19, 2014
Enriched CD44(+)/CD24(-) population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC)Fei Ma, Huihui Li, Haijuan Wang, et al.Cancer Letters|August 19, 2014
Bergamottin, a natural furanocoumarin obtained from grapefruit juice induces chemosensitization and apoptosis through the inhibition of STAT3 signaling pathway in tumor cellsSung-Moo Kim, Jong Hyun Lee, Gautam Sethi, et al.Cancer Letters|August 19, 2014
Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumorsJing Nie, Lin Liu, Xiang Li, et al.Cancer Letters|December 17, 2013
Mesenchymal stromal cell ciliogenesis is abrogated in response to tumor necrosis factor-α and requires NF-κB signalingAmélie Vézina, Eric Vaillancourt-Jean, Stéphanie Albarao, et al.Cancer Letters|December 17, 2013
LRH1 as a driving factor in pancreatic cancer growthQiushi Lin, Arihiro Aihara, Waihong Chung, et al.Cancer Letters|December 28, 2013
Bystander effects as manifestation of intercellular communication of DNA damage and of the cellular oxidative statusHolger Klammer, Emil Mladenov, Fanghua Li, et al.Cancer Letters|July 13, 2014
Development of a prediction model for lymph node metastasis in luminal A subtype breast cancer: the possibility to omit sentinel lymph node biopsyChiaki Nakauchi, Yasuto Naoi, Kenzo Shimazu, et al.Cancer Letters|July 13, 2014
Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapyJanet M Pavese, Raymond C BerganCancer Letters|July 13, 2014
Targeted biopharmaceuticals for cancer treatmentLufang Zhou, Ningning Xu, Yan Sun, et al.Cancer Letters|September 7, 2014
Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activityOliver Ou, Konrad Huppi, Sirisha Chakka, et al.Pageof 1,663